Aditxt, Inc. (ADTX)
NASDAQ: ADTX · IEX Real-Time Price · USD
1.545
-0.055 (-3.44%)
Jul 22, 2024, 10:17 AM EDT - Market open
Aditxt Employees
Aditxt had 47 employees as of December 31, 2023. The number of employees decreased by 14 or -22.95% compared to the previous year.
Employees
47
Change (1Y)
-14
Growth (1Y)
-22.95%
Revenue / Employee
$10,775
Profits / Employee
-$881,824
Market Cap
3.07M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Healthcare Triangle | 31 |
| INVO Bioscience | 30 |
| Petros Pharmaceuticals | 21 |
| Ensysce Biosciences | 7 |
| ZyVersa Therapeutics | 7 |
| Alzamend Neuro | 7 |
| CNS Pharmaceuticals | 5 |
| 60 Degrees Pharmaceuticals | 3 |
ADTX News
- 5 days ago - Aditxt and Evofem Amend and Restate Merger Agreement, Targeting September 30 Closing - Business Wire
- 7 days ago - Lupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSEC - PRNewsWire
- 25 days ago - Hello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's Healthcare - PRNewsWire
- 5 weeks ago - Evofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of Matter - PRNewsWire
- 2 months ago - Evofem Biosciences Announces Financial Results for the First Quarter of 2024 - PRNewsWire
- 2 months ago - CORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules - Business Wire
- 2 months ago - Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules - Business Wire
- 3 months ago - Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD) - Business Wire